Connect with us
We’re experimenting with AI-generated content to help deliver information faster and more efficiently.
While we try to keep things accurate, this content is part of an ongoing experiment and may not always be reliable.
Please double-check important details — we’re not responsible for how the information is used.

Biochemistry

Revolutionizing Gene Delivery with ENVLPE: A Breakthrough in Precision Medicine

A research team has developed an advanced delivery system that transports gene-editing tools based on the CRISPR/Cas9 gene-editing system into living cells with significantly greater efficiency than before. Their technology, ENVLPE, uses engineered non-infectious virus-like particles to precisely correct defective genes — demonstrated successfully in living mouse models that are blind due to a mutation. This system also holds promise for advancing cancer therapy by enabling precise genetic manipulation of engineered immune cells making them more universally compatible and thus more accessible for a larger group of cancer patients.

Avatar photo

Published

on

Here is the rewritten article:

Revolutionizing Gene Delivery with ENVLPE: A Breakthrough in Precision Medicine

Genome editing techniques have shown tremendous potential for treating genetic diseases, but delivering these molecular tools reliably to their target cells remains a significant challenge. Previous viral and non-viral delivery systems, such as adeno-associated viruses (AAVs) and lipid nanoparticles (LNPs), have limitations that hinder their effectiveness.

ENVLPE, short for “Engineered Nucleocytosolic Vehicles for Loading of Programmable Editors,” is a revolutionary delivery system designed to overcome these challenges. Led by Dr. Dong-Jiunn Jeffery Truong from the Institute for Synthetic Biomedicine at Helmholtz Munich, the research team developed ENVLPE as a non-infectious virus-like particle that can efficiently transport gene-editing tools into target cells.

“ENVLPE solves two major limitations of earlier systems,” explains Dr. Truong. “Firstly, it ensures the packaging of fully assembled gene editors, which reduces delivery effectiveness in previous methods. Secondly, it contains an extra molecular shield that protects the most vulnerable part of the editor from degradation during transport.”

In a groundbreaking study published in a leading scientific journal, the researchers tested ENVLPE in a mouse model of inherited blindness. The mice carried a disabling mutation in the Rpe65 gene, which is essential for producing light-sensitive molecules in the retina. After injecting ENVLPE into the subretinal space to correct the mutation, the animals began to respond to light stimuli again.

“The extent of restoration was astounding,” says Julian Geilenkeuser, co-first author and a doctoral researcher at the Institute for Synthetic Biomedicine. “It showed us that our particles have real therapeutic potential in a living animal.”

Compared to established systems, ENVLPE achieved significantly better results: a competing system required more than 10 times the dose to reach similar effects.

“Our goal was to build a tool that is both useful for researchers and suitable for real-world applications,” says Niklas Armbrust, also co-first author and a doctoral researcher at the Institute for Synthetic Biomedicine. “We resolved critical bottlenecks and achieved a much more efficient packaging by the delivery agents.”

ENVLPE could also open up new possibilities for adoptive T cell therapies, where immune cells taken from the patient are genetically modified in the lab so that they can specifically recognize and attack tumor cells.

These innovations address critical challenges in both in vivo gene therapies for genetically inherited diseases and ex vivo cell therapies for cancer, paving the way for important translational advancements.

“The highly modular ENVLPE system brings us substantially closer to on-demand and precise genetic modifications of complex cellular models,” says Prof. Gil Westmeyer, Director of the Institute for Synthetic Biomedicine and Professor for Neurobiological Engineering at TUM and co-senior author of the study. “It is an example of how synthetic biology can help drive medical innovation.”

The research team now seeks to use the diversity found in nature, along with recent advancements in AI-assisted protein design, to increase targeting precision by restricting the delivery of these tools to specific cell or tissue types only.

To move ENVLPE toward clinical application, the researchers are pursuing follow-up funding from translational grants and partnerships in the pharmaceutical industry. The goal is to optimize the technology for various therapeutic applications and ultimately make it available to patients.

Biochemistry

Shape-Shifting Catalysts: Revolutionizing Green Chemistry with a Single Atom

A team in Milan has developed a first-of-its-kind single-atom catalyst that acts like a molecular switch, enabling cleaner, more adaptable chemical reactions. Stable, recyclable, and eco-friendly, it marks a major step toward programmable sustainable chemistry.

Avatar photo

Published

on

By

The scientific community has witnessed a groundbreaking development in sustainable chemistry with the creation of a shape-shifting single-atom catalyst at the Politecnico di Milano. This innovative material has demonstrated the capability to selectively adapt its chemical activity, paving the way for more efficient and programmable industrial processes.

Published in the Journal of the American Chemical Society, one of the world’s most esteemed scientific journals in chemistry, this study marks a significant breakthrough in the field of single-atom catalysts. For the first time, scientists have successfully designed a material that can change its catalytic function depending on the chemical environment, much like a ‘molecular switch.’ This allows complex reactions to be performed more cleanly and efficiently, using less energy than conventional processes.

The research focuses on a palladium-based catalyst in atomic form encapsulated in a specially designed organic structure. This unique setup enables the material to ‘switch’ between two essential reactions in organic chemistry – bioreaction and carbon-carbon coupling – simply by varying the reaction conditions. The team has successfully demonstrated this phenomenon, showcasing the potential for more intelligent, selective, and sustainable chemical transformations.

Lead researcher Gianvito Vilé, lecturer at the Politecnico di Milano’s ‘Giulio Natta’ Department of Chemistry, Materials and Chemical Engineering, emphasizes the significance of their discovery: “We have created a system that can modulate catalytic reactivity in a controlled manner, paving the way for more intelligent, selective, and sustainable chemical transformations.”

The new catalyst stands out not only for its reaction flexibility but also for its stability, recyclability, and reduced environmental impact. ‘Green’ analyses conducted by the team reveal a substantial decrease in waste and hazardous reagents, making it an exemplary model for sustainable chemistry.

This study is the result of an international collaboration with esteemed institutions from around the world, including the University of Milan-Bicocca, the University of Ostrava (Czech Republic), the University of Graz (Austria), and Kunsan National University (South Korea). The joint efforts of these researchers have led to a groundbreaking achievement that has far-reaching implications for the field of green chemistry.

Continue Reading

Biochemistry

Scientists Finally Tame the Impossible: A Stable 48-Atom Carbon Ring is Achieved

Researchers have synthesized a stable cyclo[48]carbon, a unique 48-carbon ring that can be studied in solution at room temperature, a feat never achieved before.

Avatar photo

Published

on

By

The discovery of a new type of molecular carbon allotrope, known as cyclocarbon, has been a long-standing challenge for chemists. A team of researchers from Oxford University’s Department of Chemistry, led by Dr Yueze Gao and senior author Professor Harry Andersen, have successfully synthesized a stable 48-atom carbon ring in solution at room temperature. This achievement marks a significant breakthrough in the field, as previous attempts to study cyclocarbons were limited to the gas phase or extremely low temperatures (4 to 10 K).

The researchers employed a unique approach by synthesizing a cyclocarbon catenane, where the C48 ring is threaded through three other macrocycles. This design increases the stability of the molecule, preventing access to the sensitive cyclocarbon core. The team developed mild reaction conditions for the unmasking step in the synthesis process, which allowed them to achieve a stable cyclocarbon in solution at 20°C.

The cyclocarbon catenane was characterized using various spectroscopic techniques, including mass spectrometry, NMR, UV-visible, and Raman spectroscopy. The observation of a single intense 13C NMR resonance for all 48 sp1 carbon atoms provides strong evidence for the cyclocarbon catenane structure.

Lead author Dr Yueze Gao stated that achieving stable cyclocarbons in a vial at ambient conditions is a fundamental step, making it easier to study their reactivity and properties under normal laboratory conditions. Senior author Professor Harry Andersen added that this achievement marks the culmination of a long endeavor, with the original grant proposal written in 2016 based on preliminary results from 2012-2015.

The study also involved researchers from the University of Manchester, the University of Bristol, and the Central Laser Facility, Rutherford Appleton Laboratory. This collaborative effort demonstrates the power of interdisciplinary research in advancing our understanding of complex molecular systems.

This achievement has significant implications for future studies on cyclocarbons and their potential applications in various fields. The researchers’ innovative approach to synthesizing stable cyclocarbons at room temperature opens up new possibilities for exploring the properties and reactivity of these intriguing molecules.

Continue Reading

Biochemistry

“Revolutionizing Medicine: A 100x Faster Path to Life-Saving Drugs with Metal Carbenes”

Using a clever combo of iron and radical chemistry, scientists have unlocked a safer, faster way to create carbenes molecular powerhouses key to modern medicine and materials. It s 100x more efficient than previous methods.

Avatar photo

Published

on

By

Chemists have made a groundbreaking breakthrough in developing a novel method to generate highly useful chemical building blocks by harnessing metal carbenes. This achievement is expected to revolutionize the synthesis of life-saving drugs and materials development.

Typically used in chemical reactions essential for drug synthesis, carbenes are short-lived, highly reactive carbon atoms. However, creating these carbenes has been a challenging task due to limited methods and hazardous procedures.

Researchers at The Ohio State University have now developed an approach that makes producing metal carbenes much easier and safer. According to David Nagib, co-author of the study and distinguished professor in arts and sciences, “Our goal all along was to determine if we could come up with new methods of accessing carbenes that others hadn’t found before.”

The team’s innovative method uses iron as a metal catalyst and combines it with chlorine-based molecules that easily generate free radicals. This combination works to form the carbene of their choice, including many that had never been made before.

These three-sided molecular fragments, known as cyclopropanes, are vital to the synthesis of medicines and agrichemicals due to their small size and unusual energy. The researchers’ work was inspired by looking for the best ways to create these shape, which is one of the most common found in medicines.

“Our lab is obsessed with trying to get the best methods for making cyclopropanes out there as soon as possible,” said Nagib. “We have the eye on the prize of inventing better tools to make better medicines, and along the way, we’ve solved a huge problem in the carbene world.”

The study was recently published in Science, and the team’s discovery is expected to become extremely impactful. By accessing a new way of creating and classifying carbenes, scientists can simplify and improve the current wasteful, multistep process of producing them.

For consumers, this method suggests that future drugs developed by this technology may be cheaper, more potent, faster-acting, and longer-lasting. The work could prevent shortages of important medicines like antibiotics and antidepressants, as well as drugs that treat heart disease, COVID, and HIV infections, said Nagib.

Additionally, the team would like to ensure that their transformational organic chemistry tool is accessible to both big and small research labs and drug manufacturers around the world. One way to guarantee this is by continuing to improve the current technique, said Nagib.

“Our team at Ohio State came together in the coolest, most collaborative way to develop this tool,” he said. “So we’re going to continue racing to show how many different types of catalysts it could work on and make all kinds of challenging and valuable molecules.”

Continue Reading

Trending